-
1). The Revolution Medicines (
$RVMD) IPO is scheduled for Feb 12 Here is the roadshow video and S-1 https://www.sec.gov/Archives/edgar/data/1628171/000119312520022117/d799036ds1a.htm …#KRAS$MRTX$AMGNhttps://www.youtube.com/watch?v=YTcrfSJ0iAE&t=1952s … -
Forest from the trees is that
$RVMD is taking advantage of multiple avenues to optimize combination therapies in the MAPK/RAS pathway, currently one of the hottest spaces in targeted oncology.Prikaži ovu nit -
Revolution Medicines, Inc. (IPO)
$RVMD is now on RetailRoadshow. https://retailroadshow.com/?link=RVMD -
-
$RVMD: Another big#biotech#IPO next Wed. 2/12. Revolution Medicines. Expanding pool of patients who can benefit from targeted therapy. If$BDTX IPO last week is any indication, this one will outperform. S-1 --> https://www.sec.gov/Archives/edgar/data/1628171/000119312520010145/d799036ds1.htm#toc799036_12 … -
New Expected IPOs: NexPoint Real Estate Finance, Inc.
$NREF Professional Holding Corp.$PFHD Revolution Medicines, Inc.$RVMD More info about#IPO:https://finvestmonitor.com/ipomonitor -
$RVMD - IPO Update: Revolution Medicines Proposes IPO Terms. https://seekingalpha.com/article/4321000-ipo-update-revolution-medicines-proposes-ipo-terms?source=feed_f&utm_campaign=twitter_automated&utm_content=article&utm_medium=social&utm_source=twitter_automated …#business#trading#stocks -
-
Revolution Medicines has launched its IPO. Terms are as follows: Debut date 2/13 10mm shares Price Range: $14.00-$16.00
#IPO$IPO$RVMD pic.twitter.com/KWF5hdVNCC
-
.
@Rev_Medicine Maps Out an IPO to Reach Cancer’s Frontiers - by@frankvinluan https://xconomy.com/san-francisco/2020/01/17/revolution-medicines-maps-out-an-ipo-to-reach-cancers-frontiers/ …$RVMD -
For
$RVMD, unfortunately SHP-2 has major tox and the way they are trying to get around it is thru intermittent dosing. This also will be difficult to make the pitch on combo-ing the agent. A few stable a response in dose escalation. Will be all about KRAS asset that's early.Prikaži ovu nit -
ICYMI, Revolution Medicines filed for a $100M
#IPO late last week. Lead#cancer drug is in Phase 1 testing under partnership with Sanofi... https://xconomy.com/san-francisco/2020/01/17/revolution-medicines-maps-out-an-ipo-to-reach-cancers-frontiers/ …$RVMD$SNY -
Revolution Medicines is looking to have a $100M
#IPO.$RVMD#NASDAQ#StockMarket https://www.bizjournals.com/sanfrancisco/news/2020/01/17/cancer-ipo-revolution-medicines-biotech.html …
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.